BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

539267

SAMSRITA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SAMSRITA LABS LIMITED Share Price Update

As of the latest trading session, SAMSRITA LABS LIMITED share price is currently at ₹ 22.11, which is up by ₹ 0.11 from its previous closing. Today, the stock has fluctuated between ₹ 22.11 and ₹ 22.22. Over the past year, SAMSRITA LABS LIMITED has achieved a return of 5.36 %. In the last month alone, the return has been 15.48 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SAMSRITA LABS LIMITED fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    50.50

  • P/E Ratio (TTM)

    -9.36

  • Beta

    0.76

  • Book Value / share

    6.51

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    -4.94

info icon alternate text

SAMSRITA LABS LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 0.00
Operating Expense 4.94
Net Profit -4.94
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -2.17
EBITDA -4.94
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.28
Net Profit -0.28
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.19
EBITDA -0.28
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.09
Net Profit -0.09
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.06
EBITDA -0.09
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.26
Net Profit -0.26
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.18
EBITDA -0.26
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.25
Net Profit -0.25
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.17
EBITDA -0.25
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.02
Operating Expense 1.01
Net Profit -0.71
Net Profit Margin (%) -3550.00
Earnings Per Share (EPS) -0.48
EBITDA -0.71
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.02
Operating Expense 0.43
Net Profit 1.50
Net Profit Margin (%) 7500.00
Earnings Per Share (EPS) 1.01
EBITDA 1.51
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.01
Operating Expense 0.93
Net Profit -0.77
Net Profit Margin (%) -7700.00
Earnings Per Share (EPS) -0.42
EBITDA -0.76
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 8.09
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.19
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 8.28
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.17
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 8.45
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.19
EBITDA Margin -3500.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.93
ROE % 9.78
ROCE % 8.36
Total Debt to Total Equity 0.21
EBITDA Margin 7500.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 7.53
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.48
EBITDA Margin -7600.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 8.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.19
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 8.34
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.17
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 8.50
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.19
EBITDA Margin -3500.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.98
ROE % 9.58
ROCE % 8.21
Total Debt to Total Equity 0.20
EBITDA Margin 7500.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 7.97
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.17
EBITDA Margin -7600.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 15.56
Total Liabilities 15.56
Total Equity 11.97
Share Outstanding 14808706
Price to Book Ratio 1.72
Return on Assets (%) -1.82
Return on Capital (%) -1.98
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 15.55
Total Liabilities 15.55
Total Equity 12.25
Share Outstanding 14808706
Price to Book Ratio 1.78
Return on Assets (%) -1.68
Return on Capital (%) -1.81
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 15.56
Total Liabilities 15.56
Total Equity 12.52
Share Outstanding 14808706
Price to Book Ratio 2.63
Return on Assets (%) -4.54
Return on Capital (%) -4.85
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 17.12
Total Liabilities 17.12
Total Equity 13.22
Share Outstanding 14808706
Price to Book Ratio 3.17
Return on Assets (%) 8.68
Return on Capital (%) 9.31
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 16.57
Total Liabilities 16.57
Total Equity 11.15
Share Outstanding 14808706
Price to Book Ratio 5.48
Return on Assets (%) -4.65
Return on Capital (%) -5.72
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 15.67
Total Liabilities 15.67
Total Equity 12.08
Share Outstanding 14808706
Price to Book Ratio 1.72
Return on Assets (%) -1.65
Return on Capital (%) -1.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 15.63
Total Liabilities 15.63
Total Equity 12.34
Share Outstanding 14808706
Price to Book Ratio 1.78
Return on Assets (%) -1.59
Return on Capital (%) -1.72
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 15.63
Total Liabilities 15.63
Total Equity 12.59
Share Outstanding 14808706
Price to Book Ratio 2.63
Return on Assets (%) -4.51
Return on Capital (%) -4.81
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 17.20
Total Liabilities 17.20
Total Equity 13.29
Share Outstanding 14808706
Price to Book Ratio 3.17
Return on Assets (%) 8.71
Return on Capital (%) 9.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 17.22
Total Liabilities 17.22
Total Equity 11.80
Share Outstanding 14808706
Price to Book Ratio 5.48
Return on Assets (%) -4.46
Return on Capital (%) -5.44
Particulars MAR 2025 (Values in Cr)
Net Income -0.25
Cash from Operations -0.22
Cash from Investing 0.00
Cash from Financing 0.22
Net change in Cash 0.00
Free Cash Flow -0.22
Particulars MAR 2024 (Values in Cr)
Net Income -0.24
Cash from Operations -0.12
Cash from Investing 0.00
Cash from Financing 0.12
Net change in Cash 0.00
Free Cash Flow -0.12
Particulars MAR 2023 (Values in Cr)
Net Income -0.70
Cash from Operations 0.66
Cash from Investing 0.00
Cash from Financing -0.66
Net change in Cash 0.00
Free Cash Flow 0.66
Particulars MAR 2022 (Values in Cr)
Net Income 1.49
Cash from Operations -0.39
Cash from Investing 0.00
Cash from Financing 0.40
Net change in Cash 0.00
Free Cash Flow -0.39
Particulars MAR 2021 (Values in Cr)
Net Income -0.62
Cash from Operations -0.34
Cash from Investing -0.22
Cash from Financing 0.54
Net change in Cash -0.01
Free Cash Flow -0.11
Particulars MAR 2025 (Values in Cr)
Net Income -0.25
Cash from Operations -0.22
Cash from Investing 0.00
Cash from Financing 0.22
Net change in Cash 0.00
Free Cash Flow -0.22
Particulars MAR 2024 (Values in Cr)
Net Income -0.24
Cash from Operations -0.12
Cash from Investing 0.00
Cash from Financing 0.12
Net change in Cash 0.00
Free Cash Flow -0.12
Particulars MAR 2023 (Values in Cr)
Net Income -0.70
Cash from Operations 0.66
Cash from Investing 0.00
Cash from Financing -0.66
Net change in Cash 0.00
Free Cash Flow 0.66
Particulars MAR 2022 (Values in Cr)
Net Income 1.49
Cash from Operations -0.39
Cash from Investing 0.00
Cash from Financing 0.40
Net change in Cash 0.00
Free Cash Flow -0.39
Particulars MAR 2021 (Values in Cr)
Net Income -0.62
Cash from Operations -0.34
Cash from Investing -0.22
Cash from Financing 0.54
Net change in Cash -0.01
Free Cash Flow -0.11
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 750.50 39.73 5.68 26342.55 610.50 / 1035.70
KOTHARI INDUSTRIAL CORPORATION 509.20 125.73 19.81 5442.87 41.74 / 624.95
OSWAL AGRO MILLS LTD 77.79 8.26 1.09 1044.18 58.00 / 110.69
STANDARD INDUSTRIES LTD. 18.95 0.00 1.02 121.90 17.50 / 31.07
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 750.50 60.87 9.41 26342.55 610.50 / 1035.70
UTIQUE ENTERPRISES LIMITED 5.65 19.48 0.44 31.46 3.77 / 8.00
COMPUTER POINT LTD. 4.89 0.00 0.44 14.67 4.24 / 8.88
KOTHARI INDUSTRIAL CORPORATION 509.20 0.00 21.08 5442.87 41.74 / 624.95

SAMSRITA LABS LIMITED shareholding pattern

Holding

Others
68.59%
Promoter Holdings
31.4%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Krishnam Raju Kalidindi 2749630.0 (12.09%) Shareholding of Promoter and Promoter Group
Vase K B Christ 1759002.0 (7.73%) Public Shareholding
Chopperla N P Ravikanth 1616001.0 (7.1%) Public Shareholding
Mohammed Aejaz Habeeb 1479124.0 (6.5%) Shareholding of Promoter and Promoter Group
Ved Krishna Uppuluri 1175001.0 (5.16%) Public Shareholding
Syed Ameer Basha Paspala 1028427.0 (4.52%) Shareholding of Promoter and Promoter Group
K. Nirusha 1029200.0 (4.52%) Shareholding of Promoter and Promoter Group
M. Neela Reddy 692200.0 (3.04%) Public Shareholding
Morramreddy Prabha Sameera 664500.0 (2.92%) Public Shareholding
Sarvothama Reddy Morramreddygari 660136.0 (2.9%) Public Shareholding
Malathi Basaboina 500000.0 (2.2%) Public Shareholding
Mallikaaarjuna Rao Basaboini 500000.0 (2.2%) Public Shareholding
Sarada Vijay Kumari Kalidindi 465690.0 (2.05%) Shareholding of Promoter and Promoter Group
Janakirama Raju Kalidhindi 400000.0 (1.76%) Public Shareholding
Rajeswari Harika Kalidhindi 400000.0 (1.76%) Public Shareholding
Penmetsa Parvathi 393586.0 (1.73%) Shareholding of Promoter and Promoter Group
Rudraraju Srinivas Kumar 360750.0 (1.59%) Public Shareholding
Morramreddy Srinivas Chaitanya 361000.0 (1.59%) Public Shareholding
Joel Vivek Kondabattula 300000.0 (1.32%) Public Shareholding
Nikitha Korupolu 300000.0 (1.32%) Public Shareholding
Kiran Kumar Sriram 300000.0 (1.32%) Public Shareholding
Mrinalini Basaboini 250000.0 (1.1%) Public Shareholding
Mriganayani Basaboini 250000.0 (1.1%) Public Shareholding
Lakshmi Narasimha Raju Kalidindi 245600.0 (1.08%) Public Shareholding

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

SAMSRITA LABS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
22.22 0.99 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 21.60
  • 26 Days 20.30
  • 10 Days 21.10
  • 50 Days 20.20
  • 12 Days 20.90
  • 100 Days 20.30
  • 20 Days 20.40
  • 200 Days 20.20
22.22 PIVOT

First Support

21.78

First Resistance

22.43

Second Support

21.57

Second Resistance

22.87

Third Support

21.13

Third Resistance

23.08

RSI

61.27

ADX

24.08

MACD

0.56

Williams % R

-9.85

Commodity Channel Index (CCI)

161.04

Date

2025-10-31

Week

1830.00

Same Day

2213.00

Month

2116.00

1 Year

0.76

3 Year

0.46

Over 1 Month

15.48%

down

Over 1 Year

5.36%

down

Over 3 Months

-12.10%

down

Over 3 Years

-7.33%

down

Over 6 Months

0.54%

down

Over 5 Years

-13.79%

down

SAMSRITA LABS LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SAMSRITA LABS LIMITED Share Price

Samsrita Labs Limited (Formerly known Dr Habeebullah Life Sciences Limited) was incorporated on January 25, 1996. The Company name was changed from Dr Habeebullah Life Sciences Limited to Samsrita Labs Limited on October 13, 2022. The Company, initially focused on three different verticals called, Stem cell related Hospitals, Molecular Diagnostics and R&D in New Drug Discovery but due to other reasons, aimed to shifting into Bio-pharma activities like Trading, Exports & Imports, manufacturing of Bulk drugs, APIs, Specialty drugs, R&D etc through joint ventures or associations or mergers or by its own. The Company is engaged into the business of research & experimental development on natural sciences and engineering, including bio pharma and hospital services also.

In 2017, the Company changed its Main Objects clauses by venturing into the business of Bio-Pharma and also entered the following areas like New Drug Discovery including New Molecular Entity (NME - Pro Drug); Clinical Research Organization (CRO) related activities; Stem Cell - Lab, Research and Therapy; Research and Development in Bio-technology; Consultancy Division and Pharmacy; Academic Services like Courses / Lectures / Seminars on Biotechnology, Pharma, Stem Cell Research and therapy, Clinical Research and animal studies etc.; Nutraceuticals product development; Trading, exporting and importing of medicinal drugs, chemicals, re-agents etc.

In 2016-17, the Company entered into a Collaborative Agreement with Krisani Bio Sciences Private Limited for further development of NASH (Fatty Liver) Molecule and Wilson Disease Molecule on revenue sharing basis and also entered into a Collaborative Agreement with Centre For liver Research And Diagnostics (CLRD) to use their land , building, equipment and other facilities to run their business of Hospital, Diagnostics, Pharmacy, Stem cell and other bio-technology laboratories on revenue sharing basis.

A diversified healthcare company with innovation is at the forefront of research and development in stem cells & regenerative medicine, new drug discovery, RNAi therapeutics, biomarker discovery. The Company was named after late Dr.CM Habeebullah, whose dedication and passion form the backbone of the Company's core values to provide affordable, world class cutting edge healthcare facilities to all. The Company has been established as an advanced center for research and excellence in areas of Stem Cell R&D and Therapy, New Drug discovery, Molecular Diagnostics, Stem cell based multi Specialty Hospital and CRO.

Krisani Bio Sciences Private Limited ceased to be the subsidiary of the Company with effect from 12.11.2021 and was made an Associate Company because of allotment of 64,00,000 equity shares at Rs. 10/- each by Krisani Bio Sciences Private Limited, erstwhile Subsidiary of the Company on a preferential basis and as a result the shareholding of the Company in Krisani Bio Sciences Private Limited came down from 51.33% to 32.91% in 2022.

Parent organization Indian Private
NSE symbol [-]
Founded 1996
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Samsrita Labs Ltd?

Answer Field

Samsrita Labs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 22.22 as on Nov 04 2025 12:19 PM.

What is the Market Cap of Samsrita Labs Ltd Share?

Answer Field

The market cap of Samsrita Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 50.50 as on Nov 04 2025 12:19 PM.

What is the 52 Week High and Low of Samsrita Labs Ltd?

Answer Field

The 52 Week High and Low of Samsrita Labs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 26.04 and ₹ 12.19.

What is 1 year return for Samsrita Labs Ltd?

Answer Field

The 1 year returns on the stock has been 7.42%.

What is the P/E Ratio of Samsrita Labs Ltd Share?

Answer Field

As on Nov 04 2025 12:19 PM the price-to-earnings (PE) ratio for Samsrita Labs Ltd share is -9.36.

What is the PB ratio of Samsrita Labs Ltd Share?

Answer Field

As on Nov 04 2025 12:19 PM, the price-to-book (PB) ratio for Samsrita Labs Ltd share is 6.51.

How to Buy Samsrita Labs Ltd Share?

Answer Field

You can trade in Samsrita Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Samsrita Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Samsrita Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Samsrita Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59